Endometriosis and clues to the pathogenesis of ovarian cancer

CME Journal of Gynecologic Oncology

Volumn 8, Issue 1, 2003, Pages 52-56

  Kalir, Tamara ^a   Nezhat, Farr R ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

bcl 2; Clear cell carcinoma; Endometrioid carcinoma; Endometriosis; LOH; MMP 9; Ovarian cancer; p53; PTEN

Indexed keywords

KI 67 ANTIGEN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN BCL 2; PROTEIN P53;

CLEAR CELL CARCINOMA; CYTOGENETICS; ENDOMETRIOID CARCINOMA; ENDOMETRIOSIS; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HYPERPLASIA; MALIGNANT TRANSFORMATION; MOLECULAR BIOLOGY; OVARY CANCER; PATHOGENESIS; REVIEW; TUMOR SUPPRESSOR GENE;

EID: 0038576159     PISSN: 12199087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer Statistics. CA Cancer J Clin 2001; 51:15-36.
2. Barakat RR, Federici MG, Saigo PE, Robson ME, Offit K, Boyd J, Absence of premalignant histologic, molecular, or cell biologic alterations in prophylactic oophorectomy specimens from BRCA1 heterozygotes. Cancer 2000; 89: 383-390.
3. Sampson JA. Endometrial carcinoma of the ovary arising in endometrial tissue in that organ. Arch Surg 1925; 10:1-72.
4. Scully RE, Richardson G, Barlow JF. The development of malignancy in endometriosis. Clin Obstet Gynecol 1966; 9:384-411.
5. Levine PH, Abou-Nassar S, Mittal K. Extrauterine low-grade endometrial stromal sarcoma with florid endometrioid glandular differentiation. Int J Gynecol Pathol 2001; 20:395-398.
6. Vercellini P, Parazzini F, Bolis G, Carinelli S, Dindelli M, Vendola N, et al. Endometriosis and ovarian cancer. Am J Obstet Gynecol 1993; 169:181-182.
7. Gray LA, Barnes ML. Relation of endometriosis to ovarian carcinoma. Am Surg 1965; 31:798-806.
8. Brooks JJ, Wheeler JE. Malignancy arising in extragonadal endometriosis. A case report and summary of the world literature. Cancer 1977; 40:3065-3073.
9. Heaps JM, Nieberg RK, Berek JS. Malignant neoplasms arising in endometriosis. Obstet Gynecol 1990; 75:1023-1028.
10. Depriest PD, Bands ER, Powell DE, van Nagell JR, Gallion HH, Puls Le, et al. Endometrioid carcinoma of the ovary and endometriosis: the association in postmenopausal women. Gynecol Oncol 1992; 47:71-75.
11. Mostoufizadeh G, Scully R. Malignant tumors arising in endometriosis. Clin Obstet Gynecol 1980; 23:951-963.
12. Czernobilsky B, Morris WJ. A histologic study of ovarian endometriosis with emphasis on hyperplastic and atypical changes. Obstet Gynecol 1979; 53:318-323.
13. Fukunaga M, Nomura K, Ishikawa E, Ushigome S. Ovarian atypical endometriosis: its close association with malignant epithelial tumours. Histopathol 1997; 30:249-255.
14. Ogawa S, Kaku T, Amada S, Kobayashi H, Hirakawa T, Ariyoshi K, et al. Ovarian endometriosis associated with ovarian carcinoma: a clinicopathological and immunohistochemical study. Gynecol Oncol 2000; 77:298-304.
15. Seidman JD. Prognostic importance of hyperplasia and atypia in endometriosis. Int J Gynecol Pathol 1996; 15:1-9.
16. Prefumo F, Todeschini F, Fulcheri E, Venturini PL. Epithelial abnormalities in cystic ovarian endometriosis. Gynecol Oncol 2002; 84:280-284.
17. Ballouk F, Ross JS, Wolf BC. Ovarian endometriotic cysts: an analysis of cytologic atypia and DNA ploidy. Am J Clin Pathol 1994; 102:415-419.
18. Dangel A, Medchill MT, Davis G, Meloni AM, Sandberg AA. Cytogenetic studies in endometriosis tissue. Cancer Genet Cytogenet 1994; 78:172-174.
19. Jiang X, Morland S, Hitchcock A, Thomas E, Campbell I. Allelotyping of endometriosis with adjacent ovarian carcinoma reveals evidence of a common lineage. Cancer Res 1998; 58:1707-1712.
20. Jiang X, Hitchcock A, Bryan E, Watson R, Englefield P, Thomas E, et al. Microsatellite analysis of endometriosis reveals loss of heterozygosity at candidate ovarian tumor suppressor gene loci. Cancer Res 1996; 56:3534-3539.
21. Sato N, Tsunoda H, Nishida M, Morishita Y, Takimoto Y, Kubo T, et al. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell cacinoma of the ovary. Cancer Res 2000; 60:7052-7056.
22. Sato N, Nishida M, Noguchi, M. An approach to early genetic alterations in precancerous cells. Hum Cell 2000; 13:103-108.
23. Mutter GL, Ince TA, Baak JPA, Kust GA, Zhou X-P, Eng C. Molecular identification of latent precancers in histologically normal endometrium. Cancer Res 2001; 61:4311-4314.
24. Han AC, Hovenden S, Rosenblum NG, Salazar H. Adenocarcinoma arising in extragonadal endometriosis. An immunohistochemical study. Cancer 1998; 83:1163-1169.
25. Qian J, Shi Y. bcl-2 and p53 protein expressions in the malignant transformation of ovarian endometriosis. Zhonghua Zhong Liu Za Zhi 2001; 23:403-405.
26. Nezhat F, Cohen C, Rahaman J, Gretz H, Cole P, Kalir T. Comparative immunohistochemical studies of bcl-2 and p53 proteins in benign and malignant ovarian endometriotic cysts. Cancer 2002; 94:2935-2940.
27. Nezhat F, Cohen C, Rahaman J, Gretz H, Kalir T. Immunohistochemical studies of matrix metalloproteinase-9 and collagen VI in malignant endometriotic cysts and controls (in preparation).
28. Huang L-W, Garrett AP, Bell DA, Welch WR, Berkowitz RS, Mok SC. Differential expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 protein and mRNA in epithelial ovarian tumors. Gyn Oncol 2000; 77:369-376.
29. Mutter GL, Lin MC, Fitzgerald JT, Kum JB, Baak JPA, Lees J, et al. Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers. J Natl Cancer Inst (Bethesda) 2000; 92:924-930.
30. Torres J, Navarro S, Rogla I, Ripoll F, Lluch A, Garcia-Conde J, et al. Heterogeneous lack of expression of the tumour suppressor PTEN protein in human neoplastic tissues. Eur J Cancer 2001; 37:114-127.
31. Kurose K, Zhou X-P, Araki T, Cannistra SA, Maher ER, Eng C. Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas. Am J Pathol 2001; 158:2097-2106.